logo
Harnessing India's medical colleges in the fight against TB

Harnessing India's medical colleges in the fight against TB

Hindustan Times24-06-2025
India has made undeniable progress in its battle against tuberculosis (TB). The World Health Organization (WHO) acknowledged a 17.7% drop in TB incidence in the country from 237 to 195 per lakh population between 2015 and 2023 – double the pace observed globally. Despite these advancements, India continues to bear the highest TB burden globally1, making the goal of a TB-free India even more urgent. Against this backdrop, medical colleges have emerged as vital players in the national TB response - providing a template for other disease programmes to tap into their potential for a healthier India. TB (AFP)
Harnessing India's vast network of medical colleges is a cornerstone of the nation's ambitious strategy to eliminate TB by 2025. These institutions have transitioned from peripheral actors to central pillars in the fight against TB, contributing significantly to nearly every facet of the National Tuberculosis Elimination Programme (NTEP). Medical colleges have evolved beyond tertiary referral centres to become critical nodes in India's public health infrastructure and the TB elimination response. They serve patients from both within and beyond their districts and states, offering significant potential for case detection not just in TB and respiratory departments, but across all specialties.
Equipped with advanced laboratories and specialised centres, nearly all of India's 651 medical colleges are working closely with the NTEP. Notably, 336 medical colleges have centres dedicated to managing drug-resistant TB, a more complex and harder-to-treat form of the disease. With cutting-edge diagnostic tools and clinical expertise in handling health complications, these institutions are leading to better TB care and outcomes. In 2023, medical colleges notified nearly 14% of all TB cases in India – a clear sign of their growing role in this national effort.
Medical colleges are playing an increasingly important role in responding to the emerging trends in the TB epidemic. Extra-pulmonary forms of the disease that occur outside the lungs are on the rise and are generally harder to detect and treat. It now makes up 20-24% of all TB cases in India, especially among people with weaker immunity. With their advanced labs, specialist departments, and tertiary care capacity, medical colleges are uniquely positioned to deliver the multi-disciplinary care required to detect and manage these harder-to-treat cases.
Medical colleges are also well placed to design and implement innovative health solutions, with research and practice occurring side by side. For example, the Bharati Vidyapeeth Medical College in Pune repurposed its Family Adoption Programme – where each student engages with five families over three years – to integrate community-based TB screening into the existing medical curriculum. This not only helped detect cases in the community, but also taught students to recognise key TB symptoms, demonstrating a scalable model for active case finding.
One of our standout achievements has been fostering global collaborations. The ongoing partnership between AIIMS Gorakhpur and Johns Hopkins University through the TB-Free Schools initiative aimed at early detection, treatment, and prevention of TB among students in residential schools, demonstrates how Indian medical colleges can drive impactful international engagement. As this model is scaled, it reinforces what we have long championed—that medical colleges, when systematically integrated with state health systems, are among the most cost-effective and scalable platforms for delivering high-impact TB interventions.
By leveraging these institutions, we can enhance passive case finding, improve diagnosis, and ensure timely treatment. With a structured mechanism for accountability under NTEP, medical colleges can become hubs for TB management. Furthermore, they are instrumental in building a competent healthcare workforce by integrating practical, programme-oriented TB management skills into the medical curriculum, thereby preparing a new generation of doctors for the challenges of TB elimination. Through a structured framework of national, zonal, and state-level task forces, medical colleges contribute to operational research, generating vital evidence to refine public health strategies and improve patient outcomes. By embedding themselves within the community through initiatives like the Family Adoption Programme, they also bolster active case finding efforts, ensuring early diagnosis and treatment, thus playing an indispensable and multifaceted role in India's journey towards a TB-free future.
For TB and other critical public health challenges, where understanding patient behavior, treatment barriers, and local epidemiology is critical, the ability of medical colleges to connect science with ground-level implementation is key to turning policy into real-world action. They have technical expertise to strengthen surveillance systems, research capacity to strengthen monitoring and evaluation, and educational mandate to build local capability through supportive supervision.
The integration of medical colleges into the TB elimination framework has been one of the most strategic shifts under the NTEP. Medical colleges have redefined their role in public health, not only by contributing to TB management, but by setting a precedent for how academic institutions can anchor systemic change. Their success is not incidental; it is the result of sustained collaboration, institutional commitment, and a shared vision of making India TB-free. Importantly, the integration of medical colleges into the TB response offers a replicable framework for tackling other complex health challenges in India – such as anti-microbial resistance, non-communicable diseases, and neglected tropical diseases – through a blend of research, education, service delivery, and community engagement.
This article is authored by Dr Ashok Bhardwaj, professor emeritus, MM Medical & Hospital College Solan, Himachal Pradesh and chairperson of the National Task Force for Medical Colleges under NTEP and Dr Bhupendra Tripathi, deputy director, Infectious Diseases and Vaccine Delivery, Gates Foundation, India.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Puducherry TB screening: Door-to-door active case finding drives help slash incidence by 59% compared to 2015 levels
Puducherry TB screening: Door-to-door active case finding drives help slash incidence by 59% compared to 2015 levels

The Hindu

time5 hours ago

  • The Hindu

Puducherry TB screening: Door-to-door active case finding drives help slash incidence by 59% compared to 2015 levels

Punamma (68) had been unwell for two weeks with mild fever and tiredness but since she had no other major complaints neither she nor her husband (both daily wagers) paid attention till a health worker asked her to come in for tuberculosis (TB) screening at the nearby health centre as part of Puducherry's door-to-door campaign. 'I tested positive for TB and later even my husband tested positive,' she said. The two are currently under treatment and are receiving monetary and nutritional support under the TB-elimination programme. 'In a bid to curb community transmission and bring down the incidence of TB, Puducherry has been conducting door-to-door active case finding drives that especially focus on vulnerable populations who might not display TB symptoms or worse don't have the time, access or knowledge to seek medical care,' explained S. Govindarajan, mission director, Puducherry State Health Society (PSHS). He added that the idea behind the door-to-door campaign is to catch the vulnerable, at-risk patients who may be suffering without treatment and unknowingly becoming spreaders of TB. 'The idea is to ensure that no one is left behind and that nobody suffers without treatment and care. We have realised that the battle against TB needs us to ensure that patients get quicker and more accurate tests which translates into saving treatment time and saving lives,' he said. Puducherry is on a fast track toward TB elimination, as eight of its villages were declared TB-Free this World TB Day (2025) — Sivaranthagam, Ariyur (N), Vathanur, Soriyankuppam, Kudiyirupupalaym, Pooranankuppam, Sembipalayam and Korkadu. C. Venkatesh, State TB officer added that Puducherry has slashed its TB incidence by 59% compared to 2015 levels. 'All suspected cases are screened using modern diagnostic tools – AI-enabled chest X-rays and NAAT. The door-to-door active case finding drives specially focus on vulnerable populations who might not display TB symptoms,'' he said. He added that since the Union Territory is also seeing a rise in cases of diabetes and its association with TB patients are being educated and taught to monitor the condition. Diabetes is known to increases the risk of TB. Meanwhile, speaking about the implementation of the Ni-kshay Mitra programme launched in September 2022 where the State TB Cell has mobilised community members to provide nutritional baskets to TB patients Dr. Venkatesh added that through 241 Ni-kshay Mitras, or donors, Puducherry has distributed over 12,609 nutritional baskets to TB patients, ensuring treatment adherence and recovery. 'As a result, more than 85% patients receive at least three food baskets through the course of their treatment – thus enhancing their recovery. This initiative complements the DBT scheme — Ni-kshay Poshan Yojana whereby patients are paid ₹1,000 per month as nutritional support through the course of their treatment. Here also in Puducherry 85% beneficiaries receiving all their entitlements,'' he added.

Puducherry cracks down on chemists flouting rules on sale of tuberculosis medicines
Puducherry cracks down on chemists flouting rules on sale of tuberculosis medicines

Hindustan Times

time10 hours ago

  • Hindustan Times

Puducherry cracks down on chemists flouting rules on sale of tuberculosis medicines

New Delhi, The Puducherry administration has launched raids against private drug retailers flouting the ban on sale of anti-tuberculosis drugs in contravention of norms. Puducherry cracks down on chemists flouting rules on sale of tuberculosis medicines The joint enforcement raids are being conducted by the State TB Cell in collaboration with the Department of Drugs Control. The Puducherry administration in alignment with the National Tuberculosis Elimination Programme implemented the ban on the sale of anti-TB drugs by private chemists, Dr S Govindarajan, Mission Director of National Health Mission , Puducherry, told PTI. The move, initiated in 2017, followed directives from the Central TB Division, Union Health Ministry advising that anti-TB drugs should only be dispensed through government sources to ensure strict treatment adherence and minimise the risk of drug-resistant TB, he said. "Despite the initial ban, instances of non-compliance by a few chemists prompted the State TB Cell, in coordination with the Department of Drugs Control, to launch targeted joint enforcement raids," he said. These inspections aimed both at preventing unauthorised sales and to sensitise chemists regarding the public health implications of selling anti-TB drugs without notifying the State TB Officer , Dr C Venkatesh, STO, said. As part of ongoing efforts, multiple awareness meetings were held with wholesalers, retailers, and pharmacists across Puducherry, Dr Govindrajan informed. "They were instructed to stop dispensing anti-TB drugs to patients and instead report such cases using a standardised notification form," he said. These reports enabled the STO office to track patients and ensure treatment completion, Dr Govindarajan stated. "The druggists were again and again educated in a series of meeting that the selling of anti-TB drugs outside to TB patients lent to non-completion of full course of drug intake by the patient and the patient might become defaulter or the patient turned into Multi-Drug-Resistant TB case which was dreadful than the profit the druggist made from the sale," he said. Over time, these measures have yielded notable success, Dr Venkatesh said. "The sale of anti-TB drugs through private channels has significantly declined," he said. Most chemists have voluntarily withdrawn from stocking TB medications due to low demand. Additionally, private practitioners in the UT were sensitised and are now actively reporting TB cases to the STO, thus bringing more patients under the government-supported treatment regimen, Dr Venkatesh said. The State TB Cell has established three dedicated teams to conduct evening visits to private clinics for one-on-one discussions with practitioners, emphasising the importance of notifying TB cases and supporting treatment completion. "So far, eight joint raids have been conducted in the last two months, and prosecution was initiated against a chemist found violating the directives," Dr Venkatesh said. These sustained efforts have ensured that all TB patients in Puducherry are now notified under the programme and are receiving free anti-TB drugs from government sources, with continuous monitoring to ensure full treatment adherence. The initiative underscores the administration's commitment to preventing the emergence of Multi-Drug-Resistant TB , a serious threat linked to poor treatment compliance and unregulated drug availability, Dr Venkatesh added. This article was generated from an automated news agency feed without modifications to text.

India's new health push needs deeper inclusion
India's new health push needs deeper inclusion

Time of India

time11 hours ago

  • Time of India

India's new health push needs deeper inclusion

. In a country where nearly every rural household can access basic health infrastructure, one might assume the battle for public health equity is won. Yet, the numbers sober the story by a few notches: Only 65% of households consistently use improved health facilities, with even lower uptake among Scheduled Castes, Scheduled Tribes, and other marginalised groups. The paradox is clear. Bricks and mortar are in place, but trust, awareness, and access remain fragile. A 2024 scientific study based o n NFHS-5 data underscores this inequality. It found that wealthier households were dramatically more likely — up to 47 times in some cases — to access improved healthcare, even after adjusting for location and education. India's central and eastern regions continue to exhibit the starkest disparities, despite marginal improvement over past survey cycles. The socioeconomic gradient in healthcare access, in short, persists with quiet but deep severity. This divide is more than statistical. Research from urban slums in Kolkata and Bengaluru has shown that generations of deprivation can normalise poor health outcomes and reduce healthcare-seeking behaviour. As a result, even when clinics are built and services are free, utilisation lags unless interventions are grounded in community engagement and led by locally trusted actors. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Giao dịch vàng CFDs với sàn môi giới tin cậy IC Markets Tìm hiểu thêm Undo . Here, international benchmarks offer both warning and inspiration. UN Sustainable Development Goal 3 calls for universal, equitable health access by 2030, yet UNICEF-WHO data reveals that only 52% of people globally have access to essential health services — and a staggering 70% still lack basic hygiene facilities at home. India mirrors this imbalance: patchy uptake, despite broader infrastructure. In this context, Corporate Social Responsibility (CSR) emerges not as a stopgap, but as a potential catalyst for lasting change. When rooted in community participation, equity, and sustainability, CSR-led health interventions can extend the state's reach and build social trust. Consider Vedanta's SEHAT initiative, which supports primary health centres (PHCs), conducts menstrual health and addiction awareness camps, and has reached over 11,000 rural patients in Punjab. Household healthcare spending in these areas has dropped by nearly 70%, according to internal assessments. Vedanta's Nand Ghar project, in partnership with the ICDS, leverages telemedicine and mobile health vans to provide maternal and child healthcare in over 6,300 anganwadi centres. The addition of solar-powered borewells and purifiers under Project Nirmal brings a layer of climate resilience. Similarly, Hyundai Motor India Foundation's Sparsh Sanjeevani network of 35 mobile and telemedicine units has served over 1.5 million people across seven states, including in high-altitude areas of Ladakh and Jammu & Kashmir. The NTPC Foundation invested Rs 254 crore in FY 2023–24 on health and water projects, impacting 1.6 million people across 581 villages. Other examples stand out for their focus on stigmabusting. Aditya Birla Education Trust's Ujaas initiative runs a mobile van that promotes menstrual hygiene awareness and distributes sanitary pads in collaboration with women-led selfhelp groups. Tata's Aarogyatara programme has enabled 65,000 cataract surgeries and distributed over 37,000 spectacles, targeting preventable blindness. On the prevention and education front, Wipro has strengthened hygiene education in schools, and Olympus Medical Systems India has supported ENT screenings and installed sanitation facilities in schools for over 2,700 children. What these initiatives share is not just funding, but a design philosophy: preventive orientation, vulnerable population targeting, system alignment, and sustainability. These are in line with WHO-UNICEF's 2025 guidelines, which stress rightsbased, locally embedded health delivery. The Times of India CSR (Corporate Social Responsibility) and ESG (Environmental, Social, and Governance)/Social Impact Summit 2025 is expected to provide a platform for further dialogue on gender inclusion.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store